Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations

OBJECTIVE: Erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) frequently co-occur in men aged ≥40, along with lower urinary tract symptoms (LUTS) secondary to BPH. Given little real-world evidence on treatment use or satisfaction with treatment for concurrent BPH/LUTS and/or ED, this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Lulu K, Goren, Amir, Boytsov, Natalie N, Donatucci, Craig F, McVary, Kevin T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948688/
https://www.ncbi.nlm.nih.gov/pubmed/27471377
http://dx.doi.org/10.2147/PPA.S105241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948688/
https://www.ncbi.nlm.nih.gov/pubmed/27471377
http://dx.doi.org/10.2147/PPA.S105241

Ejemplares similares